News

SpeeDx Raise Additional $15 Million in Series B Funding

SpeeDx today announced it has raised $15 million in additional series B equity investment from U.S.-based Northpond Ventures. This investment …

Continue Reading

SpeeDx and LabCorp Working Together

SpeeDx and LabCorp are working together to develop and introduce new tests with the promise to help improve patient care, …

Continue Reading

Melbourne Sexual Health Continue Success with Resistance Guided Therapy

Mycoplasma genitalium (Mgen) infections treated using resistance guided therapy led to high cure rates and low levels of de novo …

Continue Reading

FIND Collaborate with SpeeDx and QuantuMDx

The Foundation for Innovative New Diagnostics (FIND) are supporting a collaboration with SpeeDx and QuantuMDx to assess the feasibility of …

Continue Reading

TGA Clears ResistancePlus® MG FleXible for Sale in Australia

The Therapeutic Goods Administration (TGA) have cleared ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, and it is now available …

Continue Reading

SpeeDx Receives CE-IVD Clearance for ResistancePlus® MG FleXible

ResistancePlus® MG FleXible for the Cepheid GeneXpert® System is now CE-IVD and available for sale in Europe. The test detects …

Continue Reading

Grant Awarded to University Collaboration with SpeeDx

The Australian Research Council (ARC) awarded almost $5 million to a collaboration with SpeeDx and over 20 other organisations, for …

Continue Reading

SpeeDx collaborate on test for premature birth risk

Researchers at The University of Western Australia and King Edward Memorial Hospital have teamed up with SpeeDx to commercialise a …

Continue Reading

SpeeDx Raise US $15 million Equity from Northpond Ventures

Up to 15 million equity investment from US-based Northpond Ventures will accelerate commercial expansion in North America and global markets. …

Continue Reading

Health Canada clears ResistancePlus® MG

This is the first commercially available test in Canada combining identification and therapeutic guidance information to support Resistance Guided Therapy …

Continue Reading